GGHC
IDXX icon

Gilder Gagnon Howe & Co’s Idexx Laboratories IDXX Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-9,470
Closed -$5.89M – 406
2021
Q3 		$5.89M Sell
9,470
-24
-0.3% -$16.1K 0.03% 236
2021
Q2 		$6M Sell
9,494
-86
-0.9% -$47.5K 0.03% 245
2021
Q1 		$4.69M Sell
9,580
-25
-0.3% -$12.5K 0.03% 245
2020
Q4 		$4.8M Sell
9,605
-73
-0.8% -$32.7K 0.02% 214
2020
Q3 		$3.81M Sell
9,678
-160
-2% -$59.2K 0.02% 211
2020
Q2 		$3.25M Buy
+9,838
New +$2.85M 0.03% 199

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Gilder Gagnon Howe & Co's IDXX Position: Q4 2021 in Review

Gilder Gagnon Howe & Co sold out of Idexx Laboratories (IDXX) in Q4 2021, closing a stake of 9,470 shares — an estimated $5.89M sold.

Gilder Gagnon Howe & Co first reported a position in IDXX in Q2 2020 and held it in 6 quarters. The position peaked at $6M in Q2 2021. 1,107 funds tracked by Wall St. Rank hold IDXX as of Q4 2021.

  • Gilder Gagnon Howe & Co reported no remaining Idexx Laboratories position as of Q4 2021 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 9,470 Idexx Laboratories shares in Q4 2021, an estimated $5.89M.
  • Gilder Gagnon Howe & Co first reported a position in Idexx Laboratories in Q2 2020 and held it in 6 quarters.
  • Gilder Gagnon Howe & Co's Idexx Laboratories position peaked at $6M in Q2 2021.
  • 1,107 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2021.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2021, filed 14 Feb 2022.